ArticleSignal transduction and targeted therapy2026
Engineering T cells with a novel PD-L1-specific TCR targeting immune and cancer cells.
Thomas Landkildehus Lisle et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it